Douglas W. Jamison
Chairman of the Board, Chief Executive Officer & Managing Director
Mr. Jamison has served as Chairman and Chief Executive Officer since January 2009; as President and Chief Operating Officer from January 2005 to December 2008; as Treasurer from March 2005 to May 2008; as a Managing Director since January 2004; as Chief Financial Officer from January 2005 to December 2007; and as Vice President from September 2002 to December 2004. He has been a member of our Board of Directors since May 2007. Since January 2009, he has served as Chairman and Chief Executive Officer of Harris & Harris Enterprises, Inc., a wholly owned subsidiary of the Company, since 2005, he has served as a Director; and from January 2005 to December 2008 he served as President . From 1998 to 2002, Mr. Jamison worked as a Senior Technology Manager at the University of Utah Technology Transfer Office, where he managed intellectual property for the University of Utah. This included assessing technologies in both the biological sciences and the physical sciences, working with patent attorneys to develop patent protection, and developing and marketing these technologies with industry. He is a Co-Editor-in-Chief, Journal of Nanotechnology Law & Business and Co-Chair of the Advisory Board, Converging Technology Bar Association and a member of the University of Pennsylvania Nano-Bio Interface Ethics Advisory Board. He was graduated from Dartmouth College (B.A.) and the University of Utah (M.S.).
Portfolio responsibilities: Ancora Pharmaceuticals, Mersana Therapeutics, Metabolon, Nextreme Thermal Solutions and Solazyme.
Daniel B. Wolfe, Ph.D.
President, Chief Operating Officer & Managing Director
Mr. Wolfe has served as President and Chief Operating Officer since January 2009; as Chief Financial Officer and as a Managing Director from January 2008 to January 2013; and as Treasurer since May 2008. He served as Principal from January 2007 to January 2008; as Senior Associate from January 2006 to January 2007; and as Vice President from July 2004 to January 2008. Since January 2009, he has served as President and a Director of Harris & Harris Enterprises, Inc., a wholly owned subsidiary of the Company. Mr. Wolfe was a consultant to Nanosys, Inc. (from 2002 to 2004), to CW Group (from 2001 to 2004), and Bioscale, Inc. (from January 2004 to June 2004), and was the Co-founder and President of Scientific Venture Assessments, Inc., a provider of scientific analysis of prospective investments for private equity placements and of scientific expertise to high-technology companies (from February 2000 to January 2002). He was graduated from Harvard University (Ph.D. and A.M. in Chemistry). He was a NSF Predoctoral Fellow at Harvard, and his thesis advisor was Professor George Whitesides. He was also graduated from Rice University (B.A. in Chemistry), where he worked with Professor Naomi Halas, and his honors included the Zevi and Bertha Salsburg Memorial Award in Chemistry and the Presidential Honor Role. He has published over 15 articles in scientific peer-reviewed journals.
Portfolio responsibilities: Champions Oncology, Enumeral Technologies, GEO Semiconductor, Laser Light Engines, Nanosys, Nantero, Nextreme Thermal Solutions and SiOnyx.
Patricia N. Egan, CPA
Chief Financial Officer
Ms. Egan has served as Chief Financial Officer since January 2013. She served as Chief Accounting Officer, as a Vice President and as Senior Controller from June 2005 to January 2013. From June 2005 to to December 2005, from August 2006 to March 2008 and from May 2008 to December 2008, she served as an Assistant Secretary. Since January 2006, she has served as Treasurer and as Secretary of Harris & Harris Enterprises, Inc., a wholly owned subsidiary of the Company. From 1996 to 2005, she served as a Manager at PricewaterhouseCoopers LLP in its financial services group from 1996 to 2005. Ms. Egan was graduated from Georgetown University (B.S., Accounting), where her honors included the Othmar F. Winkler Award for Excellence in Community Service. She is a Certified Public Accountant.
Alexei A. Andreev, Ph.D.
Executive Vice President & Managing Director
Mr. Andreev has served as an Executive Vice President and as a Managing Director since March 2005. From 2002 to March 2005, he was an Associate with Draper Fisher Jurvetson (DFJ), a venture capital firm, where he was exclusively focused on nanotechnology and material science investment opportunities. While at DFJ, he played an integral role in sourcing and funding EoPlex, Intematix, Solicore and D-Wave Systems, for which companies he served as an active Board Director or Observer. Previously, he worked for TLcom Capital Partners, a London-based venture capital fund backed by Morgan Stanley. Prior to that, he was employed by Renaissance Capital Group/Sputnik Funds, a venture capital fund in Moscow, Russia. Before he started his business career, he was a researcher at the Centre of Nanotechnology, ISAN (RAS), in Troitsk, Russia, where he was focused on optical and electrical properties of Quantum Dot heterostructures. He was graduated from the Department of Theoretical Physics of Moscow Steel & Alloys Institute (Ph.D.), where he was a recipient of the Scholarship for Outstanding Young Scientists of Russian Academia of Sciences, the Scholarship from the International Center of Fundamental Physics and Soros Scientific Foundation. He also was graduated from Moscow Steel & Alloys Institute (B.S.) with honors in Engineering/Material Sciences and from Stanford Graduate School of Business (M.B.A.).
Portfolio responsibilities: Adesto, Bridgelux, Cambrios, Contour Energy Systems, Cobalt BioFuels, D-Wave Systems, Kovio, Molecular Imprints, NeoPhotonics (NYSE: NPTN), PolyRemedy, Ultora and Xradia.
Misti Ushio, Ph.D.
Executive Vice President and Managing Director
Ms. Ushio has served as Principal since January 2010. She served as Vice President and Associate from May 2007 to December 2009. From June 2006 to May 2007, she was a Technology Licensing Officer at Columbia University, where she managed the nanotechnology and materials science invention and patent portfolios. From May 1996 to May 2006, she was employed by Merck & Co., Inc., most recently as a Senior Biochemical Engineer with the Bioprocess R&D group. She is a graduate of University College London (Ph.D., Biochemical Engineering), Lehigh University (M.S., Chemical Engineering) and Johns Hopkins University (B.S., Chemical Engineering).
Portfolio responsibilities: Ancora Pharmaceuticals, Biovex (acquired by Amgen, Inc.), Champions Oncology, Crystal IS, Ensemble Therapeutics, Enumeral Technologies, Mersana Therapeutics, Polatis, Questech, Siluria and Tetravitae.
Sandra M. Forman, Esq.
General Counsel, Chief Compliance Officer & Director of Human Resources
Ms. Forman has served as General Counsel, as Chief Compliance Officer and as Director of Human Resources since August 2004 and as our Corporate Secretary since January 2009. From 2001 to 2004, she was an Associate at Skadden, Arps, Slate, Meagher & Flom LLP, in the Investment Management Group. She served as an intern from August to December 2000 in the office of the General Counsel, United States Department of Defense, Office of the Secretary of Defense. From June to August 1999, she served as an intern for the Honorable Ronald S. Lew, United States Federal District Court, Central District of California. She was graduated from New York University (B.A.), where her honors included National Journalism Honor Society, and from the University of California Los Angeles (J.D.), where her honors included Order of the Coif and membership on the Law Review. She is currently a member of the working group for the National Venture Capital Association model documents.
Mary P. Brady, CPA
Vice President & Senior Controller
Ms. Brady has served as a Vice President and as Senior Controller since Novermber 2005 and January 2013, respectively. She served as Controller from November 2005 to January 2013. From November 2005 to March 2008, she served as an Assistant Secretary. From 2003 through 2005, she served as a senior accountant at Clarendon Insurance Company in its program accounting group from 2003 through 2005. From 2000 to 2003, she served as a senior associate at PricewaterhouseCoopers LLP in its financial services group. Ms. Brady graduated Summa Cum Laude from Lehman College (B.S., Accounting). She is a Certified Public Accountant.
As of 4:05 PM ET on 06/17/13
Quote delayed at least 20 minutes.
1450 Broadway, 24th Floor
New York, NY 10018
Phone: 212 582 0900
Fax: 212 582 9563
West Coast Office:
530 Lytton Avenue - 2nd Floor
Palo Alto, CA 94301
Phone: 650 617 3386
Fax: 650 617 3201